ÂÜÀòÂÒÂ×

David Walsey, J.D., LL.M has a diverse work experience spanning over multiple roles and industries. David is currently the Senior Vice President at MEI Pharma since May 2021, where they oversee various responsibilities. Prior to this, they served as the Vice President of Investor Relations & Corporate Communications at MEI Pharma from February 2018 to May 2021.

Before joining MEI Pharma, David worked as the Vice President of Corporate Communications at Alder Biopharmaceuticals Inc. from November 2015 to February 2018. David also held the position of Managing Director at BrewLife Agency, a W2O Company, from August 2014 to 2015.

David has a rich background in investor relations and corporate communications. David served as the Vice President of Investor Relations & Corporate Communications at Optimer Pharmaceuticals from June 2011 to 2014. Prior to that, they held the role of Senior Director of Investor Relations and Corporate Communications at AVI BioPharma from November 2009 to 2011.

Earlier in their career, David held several positions in corporate communications at Arena Pharmaceuticals, Maxim Pharmaceuticals, The Ruth Group, and Noonan Russo. David began their professional journey as an Attorney at Law in their own firm, David A. Walsey, from 1991 to 2000.

With their extensive experience and expertise in the biopharmaceutical industry, David has made significant contributions to the organizations they have been associated with.

David Walsey, J.D., LL.M has a Bachelor of Arts degree in Sociology from Franklin & Marshall College. David then pursued their Juris Doctor (J.D.) degree from Brooklyn Law School. Following that, they specialized in Tax Law/Taxation and obtained a Master of Laws (LL.M) degree from New York University School of Law. The exact years of their education are not provided.